BioSpace News Archive

Shimadzu Medical Systems USA announces the North American sales release of our newest GLIDE Technology™ family member, the RADspeed Pro style edition with POWER GLIDE for general radiography.

The Foundation for Sickle Cell Disease Research, LLC (FSCDR), which is a stand-alone, community-based medical and research practice, recently opened a new flagship location and six satellite locations. The new flagship location is located at 1685 S. State Road 7, Unit 4, Hollywood, Florida 33023.

FSD Pharma Inc. announced that it has submitted to the U.S. Food and Drug Administration an Investigational New Animal Drug Application for the use of FSD201 to treat Gastrointestinal enteropathy in dogs.

Puregraft (PG) LLC, a wholly owned subsidiary of Bimini Health Tech, announced today the publication of a clinical study demonstrating Puregraft fat grafting significantly improved knee functional status and symptom relief at 3 and 6 months, in patients with knee osteoarthritis.

Update on Ii-Key-SARS-CoV-2 vaccine program Appointment of Dr. Craig Eagle to be Chairman of the Board of NuGenerex Immuno-Oncology Inc. pending board approval. Re-Launch of Excellagen® in the VA Hospital Network Launch of Remote Patient Monitoring (RPM) Business NuGenHealth Update on Partnership & Anticipated Acquisition of AltuCell

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the first quarter ended March 31, 2021.

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), and its subsidiary Campbell Neurosciences announced today new data covered by its previously filed patents supporting the use of mesenchymal based stem cell therapy for schizophrenia.

Medicus IT (MIT), the leading healthcare-focused managed services provider (MSP) based in Alpharetta, Georgia, announced the acquisition of Health Information Technology Care (HITCare), California’s premier healthcare managed IT services provider based in Petaluma.

Digital diagnostics company Ellume today announced it has established its first U.S. manufacturing facility in Frederick, Maryland to support the domestic response to COVID-19 and other infectious diseases.

Specialty diagnostics company Precipio, Inc.(NASDAQ: PRPO), announced that it has launched a new, four-hour Acute Myeloid Leukemia (AML) HemeScreen panel to specifically determine the genetics of this aggressive, acute form of leukemia.